Inflammatory Macrophage Expansion in Pulmonary Hypertension Depends upon Mobilization of Blood-Borne Monocytes
- PMID: 29632145
- PMCID: PMC5940510
- DOI: 10.4049/jimmunol.1701287
Inflammatory Macrophage Expansion in Pulmonary Hypertension Depends upon Mobilization of Blood-Borne Monocytes
Abstract
Pulmonary inflammation, which is characterized by the presence of perivascular macrophages, has been proposed as a key pathogenic driver of pulmonary hypertension (PH), a vascular disease with increasing global significance. However, the mechanisms of expansion of lung macrophages and the role of blood-borne monocytes in PH are poorly understood. Using multicolor flow cytometric analysis of blood in mouse and rat models of PH and patients with PH, an increase in blood monocytes was observed. In parallel, lung tissue displayed increased chemokine transcript expression, including those responsible for monocyte recruitment, such as Ccl2 and Cx3cl1, accompanied by an expansion of interstitial lung macrophages. These data indicate that blood monocytes are recruited to lung perivascular spaces and differentiate into inflammatory macrophages. Correspondingly, parabiosis between congenically different hypoxic mice demonstrated that most interstitial macrophages originated from blood monocytes. To define the actions of these cells in PH in vivo, we reduced blood monocyte numbers via genetic deficiency of cx3cr1 or ccr2 in chronically hypoxic male mice and by pharmacologic inhibition of Cx3cl1 in monocrotaline-exposed rats. Both models exhibited decreased inflammatory blood monocytes, as well as interstitial macrophages, leading to a substantial decrease in arteriolar remodeling but with a less robust hemodynamic effect. This study defines a direct mechanism by which interstitial macrophages expand in PH. It also demonstrates a pathway for pulmonary vascular remodeling in PH that depends upon interstitial macrophage-dependent inflammation yet is dissociated, at least in part, from hemodynamic consequences, thus offering guidance on future anti-inflammatory therapeutic strategies in this disease.
Copyright © 2018 by The American Association of Immunologists, Inc.
Figures







Similar articles
-
Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.Am J Respir Cell Mol Biol. 2017 May;56(5):597-608. doi: 10.1165/rcmb.2016-0201OC. Am J Respir Cell Mol Biol. 2017. PMID: 28125278
-
Monocytes and interstitial macrophages contribute to hypoxic pulmonary hypertension.J Clin Invest. 2025 Jan 30;135(6):e176865. doi: 10.1172/JCI176865. J Clin Invest. 2025. PMID: 39883518 Free PMC article.
-
Heterogeneity of lung mononuclear phagocytes during pneumonia: contribution of chemokine receptors.Am J Physiol Lung Cell Mol Physiol. 2013 Nov 15;305(10):L702-11. doi: 10.1152/ajplung.00194.2013. Epub 2013 Sep 20. Am J Physiol Lung Cell Mol Physiol. 2013. PMID: 24056971 Free PMC article.
-
Origin and production of inflammatory perivascular macrophages in pulmonary hypertension.Cytokine. 2017 Dec;100:11-15. doi: 10.1016/j.cyto.2017.08.015. Epub 2017 Aug 30. Cytokine. 2017. PMID: 28855075 Free PMC article. Review.
-
Neutrophil depletion inhibits early and late monocyte/macrophage increase in lung inflammation.Front Biosci. 2006 May 1;11:1569-76. doi: 10.2741/1904. Front Biosci. 2006. PMID: 16368537 Review.
Cited by
-
Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation.Front Immunol. 2022 Jul 28;13:928300. doi: 10.3389/fimmu.2022.928300. eCollection 2022. Front Immunol. 2022. PMID: 35967318 Free PMC article.
-
Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?Int J Mol Sci. 2018 Aug 27;19(9):2534. doi: 10.3390/ijms19092534. Int J Mol Sci. 2018. PMID: 30150544 Free PMC article. Review.
-
Identification of a distinct cluster of GDF15high macrophages induced by in vitro differentiation exhibiting anti-inflammatory activities.Front Immunol. 2024 Apr 8;15:1309739. doi: 10.3389/fimmu.2024.1309739. eCollection 2024. Front Immunol. 2024. PMID: 38655264 Free PMC article.
-
Mechanisms of Pulmonary Hypertension in Acute Respiratory Distress Syndrome (ARDS).Front Mol Biosci. 2021 Jan 18;7:624093. doi: 10.3389/fmolb.2020.624093. eCollection 2020. Front Mol Biosci. 2021. PMID: 33537342 Free PMC article. Review.
-
Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension.Am J Respir Crit Care Med. 2020 Jan 15;201(2):224-239. doi: 10.1164/rccm.201903-0591OC. Am J Respir Crit Care Med. 2020. PMID: 31545648 Free PMC article.
References
-
- Hwangbo C, et al. Modulation of Endothelial BMPR2 Activity by VEGFR3 in Pulmonary Arterial Hypertension. Circulation. 2017
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous